SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5RC'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1FMO_E_ADNE351_1 (CAMP-DEPENDENTPROTEIN KINASE) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | GLY A 63VAL A 70ALA A 83VAL A 116ASN A 183LEU A 185ASP A 196 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)None5RC A4000 (-4.1A)None5RC A4000 (-3.6A) | 0.74A | 1fmoE-5es1A:28.2 | 1fmoE-5es1A:32.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1MUO_A_ADNA1_1 (AURORA-RELATEDKINASE 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 9 | GLY A 63VAL A 70ALA A 83TYR A 134ALA A 135LEU A 185 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-4.5A)5RC A4000 (-3.7A)None | 0.57A | 1muoA-5es1A:25.4 | 1muoA-5es1A:30.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OPJ_B_STIB4_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | VAL A 70ALA A 83GLU A 103VAL A 116GLY A 138ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)NoneNone5RC A4000 (-3.3A)5RC A4000 ( 3.9A) | 0.90A | 1opjB-5es1A:11.1 | 1opjB-5es1A:25.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TDN_A_LEUA487_0 (L-AMINO ACID OXIDASE) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 4 / 7 | ASN A 183HIS A 176PHE A 197ILE A 162 | 5RC A4000 (-4.1A)NoneNoneNone | 1.31A | 1tdnA-5es1A:undetectable | 1tdnA-5es1A:22.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EUF_B_LQQB401_1 (CELL DIVISIONPROTEIN KINASE 6) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70LYS A 85VAL A 116ASN A 183LEU A 185ALA A 195ASP A 196 | 5RC A4000 (-4.6A)5RC A4000 (-2.8A)None5RC A4000 (-4.1A)None5RC A4000 ( 3.9A)5RC A4000 (-3.6A) | 0.76A | 2eufB-5es1A:26.1 | 2eufB-5es1A:27.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EVA_A_ADNA498_1 (TAK1 KINASE - TAB1CHIMERA FUSIONPROTEIN) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 11 | GLY A 63VAL A 70ALA A 83TYR A 134ALA A 135LEU A 185 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-4.5A)5RC A4000 (-3.7A)None | 0.57A | 2evaA-5es1A:23.3 | 2evaA-5es1A:30.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HYY_C_STIC600_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83GLU A 103VAL A 116GLY A 138LEU A 185ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)NoneNone5RC A4000 (-3.3A)None5RC A4000 ( 3.9A) | 0.94A | 2hyyC-5es1A:11.0 | 2hyyC-5es1A:25.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IVU_A_ZD6A3015_0 (PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RETPRECURSOR) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | GLY A 63VAL A 70LYS A 85LEU A 130TYR A 134ALA A 135 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-2.8A)None5RC A4000 (-4.5A)5RC A4000 (-3.7A) | 0.46A | 2ivuA-5es1A:24.6 | 2ivuA-5es1A:27.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTHFACTOR RECEPTOR) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | GLY A 63VAL A 70ALA A 83TYR A 134GLY A 138ASP A 196 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-4.5A)5RC A4000 (-3.3A)5RC A4000 (-3.6A) | 0.74A | 2wgjA-5es1A:9.3 | 2wgjA-5es1A:22.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7J_C_B49C1294_1 (PHOSPHORYLASE BKINASE GAMMACATALYTIC CHAIN,TESTIS/LIVER ISOFORM) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 10 | ILE A 62VAL A 70ALA A 83GLY A 138ASP A 142LEU A 185 | 5RC A4000 (-4.0A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-3.3A)NoneNone | 0.88A | 2y7jC-5es1A:26.7 | 2y7jC-5es1A:29.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G0E_A_B49A9000_1 (MAST/STEM CELLGROWTH FACTORRECEPTOR) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 11 | VAL A 70ALA A 83VAL A 116TYR A 134GLY A 138LEU A 185 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)None5RC A4000 (-4.5A)5RC A4000 (-3.3A)None | 0.51A | 3g0eA-5es1A:21.9 | 3g0eA-5es1A:26.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LXK_A_MI1A1125_1 (TYROSINE-PROTEINKINASE JAK3) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | GLY A 63VAL A 70ALA A 83LYS A 85VAL A 116TYR A 134LEU A 185ALA A 195 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 (-4.5A)None5RC A4000 ( 3.9A) | 0.98A | 3lxkA-5es1A:23.6 | 3lxkA-5es1A:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LXK_A_MI1A1125_1 (TYROSINE-PROTEINKINASE JAK3) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83LYS A 85VAL A 116MET A 132TYR A 134ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)5RC A4000 ( 3.9A) | 0.75A | 3lxkA-5es1A:23.6 | 3lxkA-5es1A:28.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OXZ_A_0LIA1_1 (TYROSINE-PROTEINKINASE ABL1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | ALA A 83GLU A 103VAL A 116GLY A 138HIS A 176ALA A 195 | 5RC A4000 (-3.6A)NoneNone5RC A4000 (-3.3A)None5RC A4000 ( 3.9A) | 0.92A | 3oxzA-5es1A:22.1 | 3oxzA-5es1A:25.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RGF_A_BAXA465_1 (CYCLIN-DEPENDENTKINASE 8) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83GLU A 103TYR A 134ALA A 135HIS A 176ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)None5RC A4000 (-4.5A)5RC A4000 (-3.7A)None5RC A4000 ( 3.9A) | 0.83A | 3rgfA-5es1A:6.0 | 3rgfA-5es1A:24.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WZD_A_LEVA1201_2 (VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 5 / 5 | LYS A 85ILE A 106VAL A 116LEU A 185ASP A 196 | 5RC A4000 (-2.8A)NoneNoneNone5RC A4000 (-3.6A) | 1.17A | 3wzdA-5es1A:9.2 | 3wzdA-5es1A:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZOS_A_0LIA1000_2 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 5 / 9 | ILE A 106LEU A 110ILE A 115TYR A 134ILE A 194 | NoneNoneNone5RC A4000 (-4.5A)None | 0.82A | 3zosA-5es1A:22.4 | 3zosA-5es1A:25.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZOS_B_0LIB1000_2 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 5 / 9 | ILE A 106LEU A 110ILE A 115TYR A 134ILE A 194 | NoneNoneNone5RC A4000 (-4.5A)None | 0.83A | 3zosB-5es1A:22.5 | 3zosB-5es1A:25.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_A_0LIA1000_2 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 4 / 5 | VAL A 70ILE A 115TYR A 134ILE A 194 | 5RC A4000 (-4.6A)None5RC A4000 (-4.5A)None | 0.53A | 4c8bA-5es1A:23.1 | 4c8bA-5es1A:27.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | ALA A 83LYS A 85GLU A 103ILE A 115HIS A 176LEU A 185ALA A 195 | 5RC A4000 (-3.6A)5RC A4000 (-2.8A)NoneNoneNoneNone5RC A4000 ( 3.9A) | 0.82A | 4c8bB-5es1A:23.0 | 4c8bB-5es1A:27.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CKJ_A_ADNA2014_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE RECEPTOR RET) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 10 | GLY A 63GLY A 65VAL A 70ALA A 83TYR A 134ALA A 135 | 5RC A4000 ( 4.3A)5RC A4000 ( 3.9A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-4.5A)5RC A4000 (-3.7A) | 0.50A | 4ckjA-5es1A:24.8 | 4ckjA-5es1A:27.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CSV_A_STIA1265_1 (SRC-ABL TYROSINEKINASE ANCESTOR) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | ALA A 83GLU A 103ILE A 106VAL A 116TYR A 134LEU A 185ALA A 195 | 5RC A4000 (-3.6A)NoneNoneNone5RC A4000 (-4.5A)None5RC A4000 ( 3.9A) | 1.05A | 4csvA-5es1A:23.7 | 4csvA-5es1A:27.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CSV_A_STIA1265_1 (SRC-ABL TYROSINEKINASE ANCESTOR) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83GLU A 103ILE A 106TYR A 134LEU A 185ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)NoneNone5RC A4000 (-4.5A)None5RC A4000 ( 3.9A) | 0.93A | 4csvA-5es1A:23.7 | 4csvA-5es1A:27.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DMG_B_SAMB401_0 (PUTATIVEUNCHARACTERIZEDPROTEIN TTHA1493) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 5 / 11 | ARG A 295TYR A 218GLU A 182ALA A 181PRO A 217 | NoneNone5RC A4000 (-4.0A)NoneNone | 1.08A | 4dmgB-5es1A:undetectable | 4dmgB-5es1A:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4F3T_A_IPHA902_0 (PROTEIN ARGONAUTE-2) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 4 / 6 | LEU A 128LYS A 85LEU A 100GLU A 103 | None5RC A4000 (-2.8A)NoneNone | 1.14A | 4f3tA-5es1A:undetectable | 4f3tA-5es1A:17.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I41_A_MIXA500_1 (SERINE/THREONINE-PROTEIN KINASE PIM-1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83ASP A 142ASP A 178ASN A 183LEU A 185ASP A 196 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)NoneNone5RC A4000 (-4.1A)None5RC A4000 (-3.6A) | 0.66A | 4i41A-5es1A:26.8 | 4i41A-5es1A:28.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IFG_A_1E8A601_1 (CALMODULIN-DOMAINPROTEIN KINASE 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | GLY A 63VAL A 70ALA A 83LEU A 118LEU A 130GLY A 138GLU A 139LEU A 185 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)NoneNone5RC A4000 (-3.3A)NoneNone | 0.70A | 4ifgA-5es1A:24.1 | 4ifgA-5es1A:29.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IFG_A_1E8A601_1 (CALMODULIN-DOMAINPROTEIN KINASE 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | GLY A 63VAL A 70ALA A 83LYS A 85LEU A 118LEU A 130GLU A 182 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)NoneNone5RC A4000 (-4.0A) | 0.80A | 4ifgA-5es1A:24.1 | 4ifgA-5es1A:29.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MXY_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | VAL A 70ALA A 83LYS A 85VAL A 116MET A 132TYR A 134GLY A 138ASP A 196 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)5RC A4000 (-3.3A)5RC A4000 (-3.6A) | 0.90A | 4mxyA-5es1A:21.2 | 4mxyA-5es1A:28.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MXY_B_DB8B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | ALA A 83VAL A 116MET A 132TYR A 134GLY A 138LEU A 185ALA A 195ASP A 196 | 5RC A4000 (-3.6A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)5RC A4000 (-3.3A)None5RC A4000 ( 3.9A)5RC A4000 (-3.6A) | 0.94A | 4mxyB-5es1A:21.2 | 4mxyB-5es1A:28.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MXZ_A_DB8A601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | VAL A 70ALA A 83LYS A 85VAL A 116MET A 132TYR A 134GLY A 138ASP A 196 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)5RC A4000 (-3.3A)5RC A4000 (-3.6A) | 0.90A | 4mxzA-5es1A:21.2 | 4mxzA-5es1A:28.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MXZ_B_DB8B601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | ALA A 83VAL A 116MET A 132TYR A 134GLY A 138LEU A 185ALA A 195ASP A 196 | 5RC A4000 (-3.6A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)5RC A4000 (-3.3A)None5RC A4000 ( 3.9A)5RC A4000 (-3.6A) | 0.94A | 4mxzB-5es1A:21.2 | 4mxzB-5es1A:28.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OGR_I_ADNI401_1 (CYCLIN-DEPENDENTKINASE 9) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 9 | ILE A 62VAL A 70ALA A 83ASN A 183LEU A 185ASP A 196 | 5RC A4000 (-4.0A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-4.1A)None5RC A4000 (-3.6A) | 0.90A | 4ogrI-5es1A:25.3 | 4ogrI-5es1A:27.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4OTI_A_MI1A1001_1 (SERINE/THREONINE-PROTEIN KINASE N1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | GLY A 63GLY A 65VAL A 70ALA A 83LYS A 85VAL A 116LEU A 185ALA A 195 | 5RC A4000 ( 4.3A)5RC A4000 ( 3.9A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)NoneNone5RC A4000 ( 3.9A) | 0.71A | 4otiA-5es1A:24.6 | 4otiA-5es1A:30.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OTW_A_DB8A1101_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-3) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | VAL A 70LYS A 85VAL A 116TYR A 134GLY A 138LEU A 185ALA A 195ASP A 196 | 5RC A4000 (-4.6A)5RC A4000 (-2.8A)None5RC A4000 (-4.5A)5RC A4000 (-3.3A)None5RC A4000 ( 3.9A)5RC A4000 (-3.6A) | 1.01A | 4otwA-5es1A:21.8 | 4otwA-5es1A:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QMN_A_DB8A401_1 (SERINE/THREONINE-PROTEIN KINASE 24) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | ALA A 83GLU A 103MET A 132TYR A 134LEU A 185ALA A 195ASP A 196 | 5RC A4000 (-3.6A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)None5RC A4000 ( 3.9A)5RC A4000 (-3.6A) | 0.76A | 4qmnA-5es1A:27.3 | 4qmnA-5es1A:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QMN_A_DB8A401_1 (SERINE/THREONINE-PROTEIN KINASE 24) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | ILE A 62ALA A 83GLU A 103MET A 132TYR A 134LEU A 185ASP A 196 | 5RC A4000 (-4.0A)5RC A4000 (-3.6A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)None5RC A4000 (-3.6A) | 0.78A | 4qmnA-5es1A:27.3 | 4qmnA-5es1A:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QMN_A_DB8A401_1 (SERINE/THREONINE-PROTEIN KINASE 24) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | ILE A 62ALA A 83LYS A 85GLU A 103MET A 132TYR A 134LEU A 185 | 5RC A4000 (-4.0A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)None | 0.89A | 4qmnA-5es1A:27.3 | 4qmnA-5es1A:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QMS_A_1N1A401_1 (SERINE/THREONINE-PROTEIN KINASE 24) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 11 | ILE A 62ALA A 83LYS A 85GLU A 103MET A 132TYR A 134LEU A 185ASP A 196 | 5RC A4000 (-4.0A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 ( 4.0A)5RC A4000 (-4.5A)None5RC A4000 (-3.6A) | 0.80A | 4qmsA-5es1A:27.4 | 4qmsA-5es1A:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QMZ_A_B49A401_1 (SERINE/THREONINE-PROTEIN KINASE 24) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | ILE A 62GLY A 63VAL A 70ALA A 83MET A 132TYR A 134LEU A 185 | 5RC A4000 (-4.0A)5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 ( 4.0A)5RC A4000 (-4.5A)None | 0.65A | 4qmzA-5es1A:27.2 | 4qmzA-5es1A:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TYJ_A_0LIA801_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 4) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | ALA A 83GLU A 103ALA A 135HIS A 176LEU A 185ALA A 195 | 5RC A4000 (-3.6A)None5RC A4000 (-3.7A)NoneNone5RC A4000 ( 3.9A) | 1.06A | 4tyjA-5es1A:23.2 | 4tyjA-5es1A:24.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TYJ_A_0LIA801_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 4) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | ALA A 83GLU A 103CYH A 169HIS A 176LEU A 185ALA A 195 | 5RC A4000 (-3.6A)NoneNoneNoneNone5RC A4000 ( 3.9A) | 1.39A | 4tyjA-5es1A:23.2 | 4tyjA-5es1A:24.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4U0I_A_0LIA1001_1 (MAST/STEM CELLGROWTH FACTORRECEPTORKIT,MAST/STEM CELLGROWTH FACTORRECEPTOR KIT) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 10 | VAL A 70GLU A 103LEU A 110ILE A 115TYR A 134ILE A 194 | 5RC A4000 (-4.6A)NoneNoneNone5RC A4000 (-4.5A)None | 0.82A | 4u0iA-5es1A:22.5 | 4u0iA-5es1A:27.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4U0I_A_0LIA1001_1 (MAST/STEM CELLGROWTH FACTORRECEPTORKIT,MAST/STEM CELLGROWTH FACTORRECEPTOR KIT) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 10 | VAL A 70LEU A 110ILE A 115VAL A 116TYR A 134ILE A 194 | 5RC A4000 (-4.6A)NoneNoneNone5RC A4000 (-4.5A)None | 0.61A | 4u0iA-5es1A:22.5 | 4u0iA-5es1A:27.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4U5J_A_RXTA601_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE SRC) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 9 / 11 | GLY A 65VAL A 70ALA A 83TYR A 134GLY A 138ASN A 183LEU A 185ALA A 195ASP A 196 | 5RC A4000 ( 3.9A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-4.5A)5RC A4000 (-3.3A)5RC A4000 (-4.1A)None5RC A4000 ( 3.9A)5RC A4000 (-3.6A) | 0.85A | 4u5jA-5es1A:25.0 | 4u5jA-5es1A:29.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V01_A_0LIA1776_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 5 / 12 | ALA A 83GLU A 103ALA A 135HIS A 176ALA A 195 | 5RC A4000 (-3.6A)None5RC A4000 (-3.7A)None5RC A4000 ( 3.9A) | 0.82A | 4v01A-5es1A:22.5 | 4v01A-5es1A:28.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V01_B_0LIB1770_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 5 / 12 | ALA A 83GLU A 103ALA A 135HIS A 176ALA A 195 | 5RC A4000 (-3.6A)None5RC A4000 (-3.7A)None5RC A4000 ( 3.9A) | 0.81A | 4v01B-5es1A:22.9 | 4v01B-5es1A:28.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V04_A_0LIA1772_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | VAL A 70ALA A 83GLU A 103ALA A 135HIS A 176ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)None5RC A4000 (-3.7A)None5RC A4000 ( 3.9A) | 0.79A | 4v04A-5es1A:22.4 | 4v04A-5es1A:28.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HES_A_032A401_1 (MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | VAL A 70ALA A 83TYR A 134ALA A 135ASP A 142GLY A 198 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-4.5A)5RC A4000 (-3.7A)NoneNone | 1.15A | 5hesA-5es1A:7.5 | 5hesA-5es1A:27.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HES_A_032A401_1 (MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | VAL A 70TYR A 134ALA A 135ASP A 142PHE A 197GLY A 198 | 5RC A4000 (-4.6A)5RC A4000 (-4.5A)5RC A4000 (-3.7A)NoneNoneNone | 1.33A | 5hesA-5es1A:7.5 | 5hesA-5es1A:27.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HES_B_032B401_1 (MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83LYS A 85TYR A 134ALA A 135ASP A 142GLY A 198 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)5RC A4000 (-4.5A)5RC A4000 (-3.7A)NoneNone | 1.19A | 5hesB-5es1A:22.5 | 5hesB-5es1A:27.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HES_B_032B401_1 (MITOGEN-ACTIVATEDPROTEIN KINASEKINASE KINASE MLT) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | VAL A 70LYS A 85TYR A 134ALA A 135ASP A 142PHE A 197 | 5RC A4000 (-4.6A)5RC A4000 (-2.8A)5RC A4000 (-4.5A)5RC A4000 (-3.7A)NoneNone | 1.07A | 5hesB-5es1A:22.5 | 5hesB-5es1A:27.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I9X_A_DB8A1001_1 (EPHRIN TYPE-ARECEPTOR 2) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | ILE A 62ALA A 83LYS A 85TYR A 134GLY A 138LEU A 185 | 5RC A4000 (-4.0A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)5RC A4000 (-4.5A)5RC A4000 (-3.3A)None | 0.71A | 5i9xA-5es1A:23.5 | 5i9xA-5es1A:26.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IZJ_G_AZ1G2_1 (CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA47P-AZ1-DAR-DAR) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 4 / 7 | GLY A 63GLY A 65VAL A 70LYS A 85 | 5RC A4000 ( 4.3A)5RC A4000 ( 3.9A)5RC A4000 (-4.6A)5RC A4000 (-2.8A) | 0.34A | 5izjA-5es1A:17.7 | 5izjA-5es1A:32.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5J5X_B_AZ1B2_1 (CAMP-DEPENDENTPROTEIN KINASECATALYTIC SUBUNITALPHA47P-AZ1-DAL-DAR-DAR-DAR-DAR) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 5 / 7 | GLY A 63GLY A 65VAL A 70LYS A 85ASP A 196 | 5RC A4000 ( 4.3A)5RC A4000 ( 3.9A)5RC A4000 (-4.6A)5RC A4000 (-2.8A)5RC A4000 (-3.6A) | 0.57A | 5j5xA-5es1A:28.4 | 5j5xA-5es1A:32.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L2I_A_LQQA900_1 (CYCLIN-DEPENDENTKINASE 6) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | GLY A 63VAL A 70ALA A 83VAL A 116LEU A 185ALA A 195 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)NoneNone5RC A4000 ( 3.9A) | 0.65A | 5l2iA-5es1A:8.0 | 5l2iA-5es1A:27.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LVN_A_ADNA402_1 (3-PHOSPHOINOSITIDE-DEPENDENT PROTEINKINASE 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 11 | GLY A 63VAL A 70ALA A 83VAL A 116ALA A 135GLU A 139GLU A 182LEU A 185 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)None5RC A4000 (-3.7A)None5RC A4000 (-4.0A)None | 0.60A | 5lvnA-5es1A:29.6 | 5lvnA-5es1A:32.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5LVN_A_ADNA402_1 (3-PHOSPHOINOSITIDE-DEPENDENT PROTEINKINASE 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 11 | GLY A 63VAL A 70ALA A 83VAL A 116TYR A 134ALA A 135GLU A 139LEU A 185 | 5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)None5RC A4000 (-4.5A)5RC A4000 (-3.7A)NoneNone | 0.50A | 5lvnA-5es1A:29.6 | 5lvnA-5es1A:32.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MAF_A_XINA403_1 (MATERNAL EMBRYONICLEUCINE ZIPPERKINASE) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | ILE A 62GLY A 63VAL A 70ALA A 83LYS A 85GLU A 103TYR A 134 | 5RC A4000 (-4.0A)5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 (-4.5A) | 0.65A | 5mafA-5es1A:37.1 | 5mafA-5es1A:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MAF_A_XINA403_1 (MATERNAL EMBRYONICLEUCINE ZIPPERKINASE) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 8 / 12 | ILE A 62GLY A 63VAL A 70ALA A 83LYS A 85TYR A 134GLY A 138GLU A 139 | 5RC A4000 (-4.0A)5RC A4000 ( 4.3A)5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)5RC A4000 (-4.5A)5RC A4000 (-3.3A)None | 0.72A | 5mafA-5es1A:37.1 | 5mafA-5es1A:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OWR_A_1N1A401_1 (SERINE/THREONINE-PROTEIN KINASE 10) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 4 / 8 | ALA A 83GLU A 103LEU A 185ASP A 196 | 5RC A4000 (-3.6A)NoneNone5RC A4000 (-3.6A) | 0.72A | 5owrA-5es1A:22.7 | 5owrA-5es1A:28.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TE0_A_XINA401_1 (AP2-ASSOCIATEDPROTEIN KINASE 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 6 / 12 | LEU A 72ALA A 83GLU A 103VAL A 116GLY A 138LEU A 185 | None5RC A4000 (-3.6A)NoneNone5RC A4000 (-3.3A)None | 0.62A | 5te0A-5es1A:27.3 | 5te0A-5es1A:28.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZV2_A_LEVA801_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83GLU A 103TYR A 134ALA A 135GLY A 138ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)None5RC A4000 (-4.5A)5RC A4000 (-3.7A)5RC A4000 (-3.3A)5RC A4000 ( 3.9A) | 0.87A | 5zv2A-5es1A:22.4 | 5zv2A-5es1A:11.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZV2_B_LEVB801_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83LYS A 85GLU A 103ALA A 135GLY A 138ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 (-3.7A)5RC A4000 (-3.3A)5RC A4000 ( 3.9A) | 0.76A | 5zv2B-5es1A:22.8 | 5zv2B-5es1A:11.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZV2_B_LEVB801_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 3 / 3 | TYR A 134LEU A 185ASP A 196 | 5RC A4000 (-4.5A)None5RC A4000 (-3.6A) | 0.89A | 5zv2B-5es1A:22.8 | 5zv2B-5es1A:11.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BSD_A_1N1A901_0 (EPITHELIAL DISCOIDINDOMAIN-CONTAININGRECEPTOR 1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83LYS A 85GLU A 103TYR A 134GLY A 138LEU A 185 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)None5RC A4000 (-4.5A)5RC A4000 (-3.3A)None | 0.72A | 6bsdA-5es1A:22.0 | 6bsdA-5es1A:12.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HD4_A_STIA604_0 (TYROSINE-PROTEINKINASE ABL1) |
5es1 | MAP/MICROTUBULEAFFINITY-REGULATINGKINASE 4 (Homosapiens) | 7 / 12 | VAL A 70ALA A 83LYS A 85GLU A 103VAL A 116LEU A 185ALA A 195 | 5RC A4000 (-4.6A)5RC A4000 (-3.6A)5RC A4000 (-2.8A)NoneNoneNone5RC A4000 ( 3.9A) | 1.07A | 6hd4A-5es1A:17.0 | 6hd4A-5es1A:14.51 |